AI Verdict
LEXX has stronger fundamentals based on our AI analysis.
LEXX vs LENZ Fundamental Comparison
| Metric | LEXX | LENZ |
|---|---|---|
| Revenue | $0.0 | $19.1M |
| Net Income | $-1.6M | $-82.1M |
| Net Margin | N/A | -430.3% |
| ROE | -32.5% | -28.9% |
| ROA | -26.4% | -26.8% |
| Current Ratio | 3.68x | 14.23x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-0.07 | $-2.85 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LEXX vs LENZ: Frequently Asked Questions
Is LEXX or LENZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LEXX has stronger fundamentals. LEXX is rated SELL (72% confidence) while LENZ is rated STRONG SELL (80% confidence). This is not investment advice.
How does LEXX compare to LENZ fundamentally?
Lexaria Bioscience Corp. has ROE of -32.5% vs LENZ Therapeutics, Inc.'s -28.9%. Net margins are N/A vs -430.3% respectively.
Which stock pays higher dividends, LEXX or LENZ?
LEXX has a dividend yield of N/A or no dividend while LENZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LEXX or LENZ for long term?
For long-term investing, consider that LEXX has SELL rating with 72% confidence, while LENZ has STRONG SELL rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LEXX vs LENZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LEXX vs LENZ, the AI consensus favors LEXX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.